December 4, 2019
The Honorable Maggie Hassan
U.S. Senate
324 Hart Senate Office Building
Washington, DC 20510
The Honorable Susan Collins
U.S. Senate
413 Dirksen Senate Office Building
Washington, DC 20510
Dear Senators Hassan and Collins:
On behalf of the 80 organizations below, we write to express our support for the Opioid Workforce Act of 2019 (S.2892). This thoughtful, bipartisan legislation would provide Medicare support for an additional 1,000 graduate medical education (GME) positions over five years in hospitals that have, or are in the process of establishing, accredited residency programs in addiction medicine, addiction psychiatry, or pain medicine. We greatly appreciate Congress’ commitment to advancing policies that would strengthen the health care workforce serving on the front lines of the nation’s opioid epidemic.
More Advocacy Letters
Advocacy Letter
MGMA to DEA: Issue proposed telehealth rule (April 2, 2024)
Advocacy Letter
MGMA letter to Congress on LDT proposed rule (March 20, 2024)
Advocacy Letter
March 14, 2024 - MGMA urges permanent telehealth reform
Advocacy Letter
December 4, 2023: MGMA comments on proposed LDT rule
Advocacy Letter
November 13, 2023: MGMA comments on Section 504
Advocacy Letter
November 7, 2023: MGMA feedback on Senate healthcare package
Advocacy Letter
November 1, 2023: MGMA requests pause on LDT rulemaking
Advocacy Letter
October 31, 2023: MGMA urges budget neutrality reforms
